Developing Story: CureWise Goes Live - The AI Platform Built by Cancer Patients, for Cancer Patients
You have ten minutes with your oncologist. Ten minutes to ask the right questions, understand what's happening inside your body, and make decisions that could change everything. For most cancer patients, that's not enough time — and nobody taught you how to prepare.
CureWise was built to change that. On June 20th, the AI platform created by cancer patients Steve Brown and Lisa Booth officially launched. On this episode of Live From Stage 4, we sit down with Steve, Lisa, and real beta users Lynda and Todd Weatherby to find out what it actually does, how it works, and why it matters.
Developing Story: The Camizestrant Vote — When Your Blood Test Knows Before Your Scan Does
Six MBC patient advocates join host Victoria Goldberg to break down the FDA advisory committee's vote on camizestrant and the SERENA-6 trial. The panel unpacks what the vote really means, whether the science of molecular progression is ready for clinical practice, and why patient advocates need a seat at the table before trials are designed.
Front Row Seat: We'll Never Cure Cancer Without AI, Say Steve Brown & Lisa Booth
When Steve Brown's doctors missed his rare blood cancer for months, he turned to AI for answers. The system he built spotted the warning signs immediately—the same lab results his physicians had dismissed.
Now, as CEO of CureWise, Steve and patient advocate Lisa Booth are pioneering a new approach to cancer care: using AI agents trained as specialist doctors to help patients navigate treatment options, find clinical trials, and advocate effectively with their oncologists.
"There's a gap between what's possible and what most people are getting," Steve explains. "Cancer isn't just one disease. Everybody has their own unique version of it."
Lisa, an 11-year metastatic breast cancer survivor, adds: "My oncologist sees 600 patients. CureWise empowers me to show up to that seven-minute appointment with the right questions already researched and the clinical trials already identified."
This conversation explores how AI is transforming patient empowerment—and why knowledge might just save your life.
MBC Insiders: MBC Awareness Day and More
This is a special episode released Oct 13 for National Metastatic Breast Cancer Awareness Day. It is the first in our recurring series, we call “MBC Insiders.” We’ll explore the issues that matter most to people with MBC, including how the language clinicians and media use can harm or help, and candid conversations about progression and the idea of “cure.” Stay tuned for an important, honest discussion.